At the recently concluded Canton Fair, WUMO, as a brand-new product, captured the attention of global distributors right from its debut. We deeply understand that consumers worldwide are universally grappling with "excessive eye strain" and "digital eye fatigue". WUMO is dedicated to solving this widespread problem, pioneering an entirely new category of "Eye Health Technology".
During the exhibition, the WUMO booth was bustling. Many overseas distributors were drawn in by the product's design and user experience. What moved us most was not just their initial inquiries, but that many clients returned to our booth multiple times to discuss the design details of the WUMO Ultrasonic Eye Mister and viable regional partnership strategies.
We summarized the reasons for winning this high recognition from our partners:
Ultimate Safety & Efficacy: Beyond the comfortable experience, WUMO utilizes a detachable magnetic atomizer and single-use sterile eye solution pods, fundamentally eliminating the risk of bacterial cross-contamination. Concurrently, its micron-level particles and high-efficiency atomization process increase the liquid absorption rate by 200%.
Backed by China's Top Scientific Team: The eye solution formula was co-developed with top scientists from the Chinese Academy of Sciences (CAS). We also have Liu Yang (former President of the Society for Free Radical Research-Asia) serving as a consultant, providing crucial scientific support and methodological guidance for the scientific and safety evaluation of WUMO's eye solution.
Market Potential and a High-Repurchase Profit Model: The most critical point is the universally recognized global market potential for "digital eye fatigue" solutions. Furthermore, WUMO's design for a long-term, high-repurchase profit model can deliver sustainable business growth for our distributors.
The conclusion of the Canton Fair was not an end, but a new beginning. According to statistics from WUMO's customer database, we established contact with 480 clients from 69 countries during the event. The top 5 countries were Russia, India, France, Korea, and the United States. Among them, 52% of clients tried and purchased samples on-site. An additional 9% of clients contacted us online after the fair to purchase more samples for in-depth testing within their teams and target markets.
This not only validates the technological substance of WUMO's product but also confirms the high level of market attention on this emerging category of atomized eye care.
As of now, we have received further inquiries and trial sales cooperation intentions from multiple markets, including Germany, France, India, and Korea. Concurrently, WUMO has already entered the commercial contract preparation stage with partners from Australia, Hong Kong, and Russia. During this process, many distributors have been actively communicating with us to advance our mutual cooperation and coordinating with their local teams. WUMO's China-based business team and the CAS R&D team are also providing customized solutions for clients with different needs.
Finally, we thank every friend who stopped by, experienced our product, and engaged in discussion. It is your attention that strengthens WUMO's mission to integrate technological innovation with visual health. WUMO will continue to use science as its cornerstone and user experience as its core, relentlessly delivering more comfortable, safe, and cutting-edge eye care products. As a new brand for our company, we are thrilled and look forward to joining hands with more global partners to cultivate the multi-billion-dollar "digital eye fatigue" blue ocean, achieving long-term market value and a win-win future.
